 |
2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| EU Market Approval | EU |
| EU Designation Date | 2015-10-09 00:00:00 |
| Sponsor | GenKyoTex Innovation S.A.S |
| |
2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| EU Market Approval | EU |
| EU Designation Date | 2015-10-09 00:00:00 |
| Sponsor | GenKyoTex Innovation S.A.S |